SBP solbec pharmaceuticals limited

genentech up $11 billion, page-4

  1. skint
    5,995 Posts.
    lightbulb Created with Sketch. 162
    clock Created with Sketch.
    16/03/05
    09:57
    Post #: 832433
    DNAs(Genentech) Avastin was approved about a year ago for use on colon cancer . The $11B jump was just for the new approval for Avastin on NSCLC . Indications are that Coramsine will raise the bar considerably higher again . It is my guess that Solbec will probably concentrate on orphan drug uses , such as melonoma and mesothelioma with the prospect of accellerated approval before trials are completed .
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
NEWS BPM Acquires High-Grade Forelands Gold Project with Near-Surface Mineralisation
right-arrow Created with Sketch.
VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
NEWS Gold Mountain Expands Anomalous Rare Earths Areas at Down Under Project
right-arrow Created with Sketch.
NEWS Activeport Secures Network Transformation Contract with Ishan Technologies
right-arrow Created with Sketch.
HAR Maiden Drilling Program to Commence at Ibel South Gold Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.